Prooxidant-antioxidant balance and antioxidized LDL antibody level values and cardiac function in patients with coronary artery disease

Cardiology (Switzerland)

Volumn 122, Issue 4, 2012, Pages 203-209

  Rahsepar, Amir Ali ^a,b   Mirzaee, Asadollah ^a,b   Moodi, Fatemeh ^a   Moohebati, Mohsen ^a   Tavallaie, Shima ^b   Eshraghi, Ali ^a   Alavi, Maryam Sadat ^a   Khorashadizadeh, Fatemeh ^a   Pourghadamyari, Hossein ^b   Paydar, Roghayeh ^a   Amini, Maral ^a   Khojasteh, Roshanak ^b   Mousavi, Somayeh ^a   Sahebi, Maryam ^a,b   Ghayour Mobarhan, Majid ^a,b   Ferns, Gordon A A ^c  

^a Department of Environmental and Radiological Health Sciences   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Antibody; Antioxidized low density lipoprotein; Coronary artery disease; Prooxidant antioxidant balance

Indexed keywords

ANTIBODY; ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; MALONDIALDEHYDE ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; OXIDIZING AGENT; PROOXIDANT; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARAMETERS; PRIORITY JOURNAL; PROOXIDANT ANTIOXIDANT BALANCE; SYSTOLIC BLOOD PRESSURE;

ANTIBODIES; ANTIOXIDANTS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84864399174     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000339273     Document Type: Article

References (38)

1. Thom TJ: International mortality from heart disease: rates and trends. Int J Epidemiol 1989; 18: S20-S28. (Pubitemid 19270188)
2. Bierman EL: George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterio-scler Thromb 1992; 12:647-656.
3. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al: Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superox-ide dismutase. Circulation 2002; 106: 3073-3078. (Pubitemid 35440291)
4. Ghayour-Mobarhan M, Rahsepar AA, Tavallaie S, Rahsepar S, Ferns GA: The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem 2009; 48:27-72.
5. Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, et al: Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004; 44: 1996-2002. (Pubitemid 39473284)
6. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Boga-vac-Stanojevic N, et al: Correlation of oxida-tive stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007; 40: 181-187. (Pubitemid 46111070)
7. Virella G, Munoz JF, Galbraith GM, Gissing-er C, Chassereau C, Lopes-Virella MF: Activation of human monocyte-derived macro-phages by immune complexes containing low-density lipoprotein. Clin Immunol Im-munopathol 1995; 75: 179-189.
8. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK: LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arte-rioscler Thromb Vasc Biol 2001; 21:108-114. (Pubitemid 32061934)
9. Stemme S, Faber B, Holm J, Wiklund O, Wit-ztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995; 92:3893-3897.
10. Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y: Antibodies against oxidized LDL and carotid artery intima-me-dia thickness in a healthy population. Arte-rioscler Thromb Vasc Biol 2000; 20:703-707. (Pubitemid 30151684)
11. Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, et al: Antibodies to oxidized LDL and LDL-contain-ing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clin Immunol 1999; 90: 165-172. (Pubitemid 29162161)
12. McDowell A, Young IS, Wisdom GB: Auto-antibodies to malondialdehyde- modified low-density lipoprotein in patients with an-giographically confirmed coronary artery disease. J Pharm Pharmacol 2002; 54:1651-1657. (Pubitemid 36018814)
13. Shaw PX, Horkko S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, et al: Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macro-phages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 2001; 21:1333-1339. (Pubitemid 34219841)
14. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, et al: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000; 148: 171-177.
15. Su J, Georgiades A, Wu R, Thulin T, de FU, Frostegard J: Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 2006; 188: 160-166. (Pubitemid 44160704)
16. Tornvall P, Waeg G, Nilsson J, Hamsten A, Regnstrom J: Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis 2003; 167: 347-353. (Pubitemid 36773534)
17. Virella G, Carter RE, Saad A, Crosswell EG, Game BA, Lopes-Virella MF: Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. Clin Immunol 2008; 127: 394-400. (Pubitemid 351836069)
18. Virella G, Thorpe SR, Alderson NL, Derrick MB, Chassereau C, Rhett JM, et al: Definition of the immunogenic forms of modified human LDL recognized by human autoanti-bodies and by rabbit hyperimmune antibodies. J Lipid Res 2004; 45:1859-1867. (Pubitemid 40990878)
19. Parhami F, Fang ZT, Fogelman AM, Andal-ibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophos-phate. J Clin Invest 1993; 92:471-478. (Pubitemid 23209031)
20. Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G: A novel assay for the evaluation of the prooxidant-antiox-idant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007; 40: 248-254. (Pubitemid 46108709)
21. Alamdari DH, Ghayour-Mobarhan M, Ta-vallaie S, Parizadeh MR, Moohebati M, Gha-foori F, et al: Prooxidant-antioxidant balance as a new risk factor in patients with an-giographically defined coronary artery disease. Clin Biochem 2008; 41: 375-380.
22. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003; 91:7A-11A. (Pubitemid 36351457)
23. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC: Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004; 256:308-315. (Pubitemid 39304342)
24. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, et al: Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004; 109: 714-721. (Pubitemid 38222889)
25. Garcia MJ, Thomas JD, Klein AL: New Dop-pler echocardiographic applications for the study of diastolic function. J Am Coll Car-diol 1998; 32:865-875. (Pubitemid 28459571)
26. Rahsepar AA, Pourghadamyari H, Moohe-bati M, Parizadeh SM, Tavallaie S, Paydar R, et al: Prooxidant-anti-oxidant balance is not associated with extent of coronary artery disease. Clin Biochem 2011; 44: 1304-1308.
27. Rahsepar AA, Mirzaee A, Moodi F, Moohe-bati M, Tavallaie S, Eshraghi A, et al: Anti-heat shock protein 27 titers and oxidative stress levels are elevated in patients with valvular heart disease. Angiology 2012, E-pub ahead of print.
28. Shanati A, Rivlin Y, Shnizer S, Rosenschein U, Goldhammer E: Serum oxidizability potential of ischemic heart disease patients is associated with exercise test results and disease severity. World J Cardiol 2009; 1:46-50.
29. Belch JJ, Bridges AB, Scott N, Chopra M: Oxygen free radicals and congestive heart failure. Br Heart J 1991; 65: 245-248.
30. Betteridge DJ: What is oxidative stress? Metabolism 2000; 49:3-8. (Pubitemid 30091785)
31. Pandya DP: Oxidant injury in coronary heart disease (part-I). Compr Ther 2001; 27: 284-292. (Pubitemid 33108193)
32. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795. (Pubitemid 24283962)
33. Sayar N, Terzi S, Yilmaz HY, Tangurek B, Bilsel T, Cakmak N, et al: Exercise-induced increase in lipid peroxidation in patients with chronic heart failure: relation to exercise intolerance. Cardiolog y 2007; 108: 307-313. (Pubitemid 350126475)
34. Serdar Z, Yesilbursa D, Dirican M, Sarandol E, Serdar A: Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease. Cell Biochem Funct 2007; 25:655-664. (Pubitemid 351202352)
35. Podrez EA: Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol 2010; 37: 719-725.
36. Fang JC, Kinlay S, Behrendt D, Hikita H, Witztum JL, Selwyn AP, et al: Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterio-scler Thromb Vasc Biol 2002; 22:2044-2048. (Pubitemid 36025212)
37. Tsimikas S, Palinski W, Witztum JL: Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21:95-100. (Pubitemid 32061933)
38. van Berkel TJ, De Rijke YB, Kruijt JK: Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and en-dot helia l liver cel ls. J Biol Chem 1991; 266: 2282-2289. (Pubitemid 21909061)